Oragenics Inc (OGEN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $0.87
• Market Cap: $3.30M
• P/E Ratio: 0.02
• EPS: $48.21
• 52-Week High: $9.60
• 52-Week Low: $0.61

Market Sentiment

Oragenics Inc currently has a Bullish sentiment score of 0.54.

About Oragenics Inc

Oragenics, Inc. is a biotechnology company based in Tampa, Florida, focused on the development of innovative antibiotics and therapies for infectious diseases, including those caused by antibiotic-resistant bacteria. The company is actively pursuing novel drug candidates that leverage its proprietary technologies to address critical healthcare challenges. With a commitment to advancing healthcare solutions, Oragenics aims to contribute significantly to the global fight against infections, tar...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Oragenics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OGEN pay dividends?

Oragenics Inc (OGEN) does not currently pay a regular dividend.

What is OGEN's P/E ratio?

Oragenics Inc has a price-to-earnings (P/E) ratio of 0.02.

What is OGEN's market cap?

Oragenics Inc (OGEN) has a market capitalization of $3.30M with a current stock price of $0.87.